Skip to Main content Skip to Navigation
Journal articles

The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.: CD8+ T-cell responses change after type 1 diabetes onset

Abstract : OBJECTIVE: Islet-reactive CD8(+) T-cells play a key role in the pathogenesis of type 1 diabetes in the NOD mouse. The predominant T-cell specificities change over time, but whether similar shifts also occur after clinical diagnosis and insulin treatment in type 1 diabetic patients is unknown. RESEARCH DESIGN AND METHODS: We took advantage of a recently validated islet-specific CD8(+) T-cell gamma-interferon enzyme-linked immunospot (ISL8Spot) assay to follow responses against preproinsulin (PPI), GAD, insulinoma-associated protein 2 (IA-2), and islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) epitopes in 15 HLA-A2(+) adult type 1 diabetic patients close to diagnosis and at a second time point 7-16 months later. RESULTS: CD8(+) T-cell reactivities were less frequent at follow-up, as 28.6% of responses tested positive at type 1 diabetes diagnosis vs. 13.2% after a median of 11 months (P = 0.003). While GAD and IA-2 autoantibody (aAb) titers were unchanged in 75% of cases, the fraction of patients responding to PPI and/or GAD epitopes by ISL8Spot decreased from 60-67 to 20% (P < 0.02). The previously subdominant IA-2(206-214) and IGRP(265-273) peptides were newly targeted, thus becoming the immunodominant epitopes. CONCLUSIONS: Shifts both in frequency and in immunodominance of CD8(+) T-cell responses occur more rapidly than do changes in aAb titers. These different kinetics may suggest complementary clinical applications for T-cell and aAb measurements.
Complete list of metadatas

Cited literature [41 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00266516
Contributor : Roberto Mallone <>
Submitted on : Monday, March 24, 2008 - 10:03:31 AM
Last modification on : Saturday, May 30, 2020 - 10:40:00 PM
Long-term archiving on: : Friday, May 21, 2010 - 12:50:03 AM

Identifiers

Collections

Citation

Emanuela Martinuzzi, Giulia Novelli, Matthieu Scotto, Philippe Blancou, Jean-Marie Bach, et al.. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.: CD8+ T-cell responses change after type 1 diabetes onset. Diabetes, American Diabetes Association, 2008, 57 (5), pp.1312-20. ⟨10.2337/db07-1594⟩. ⟨inserm-00266516⟩

Share

Metrics

Record views

635

Files downloads

1412